source
- FDA approves AstraZeneca’s baxdrostat for certain patients with hypertensionOne of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been approved by the FDA, the drugmaker said Monday. The blood ...Endpoints · 2mo ago↗ source
- Opinion: ‘Patient autonomy’ has nothing to do with childhood vaccine policiesOpinion: Vaccine policy it is not a matter of autonomy at all, because infants do not decline vaccination — their parents do.STAT · 2mo ago↗ source
- STAT+: The China question is tearing biotech apartChina's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?STAT · 2mo ago↗ source